Impact of Hepatitis C virus Infection and direct-acting Oral Antiviral Drugs on glycaemic state in Type 2 Diabetic Patients | ||||
Benha Medical Journal | ||||
Article 16, Volume 38, Issue 1, April 2021, Page 185-195 PDF (516.3 K) | ||||
Document Type: Original Article | ||||
DOI: 10.21608/bmfj.2021.58139.1371 | ||||
View on SCiNiTO | ||||
Authors | ||||
Ayman ElBadawy1; Mohamed ElSayed2; Islam Abdullatif 3; Rasha AbdelMoneim1 | ||||
1Internal Medicine Faculty of Medicine, Banha University | ||||
2Professor Professor of Internal Medicine Head of Internal Medicine Department and Endocrinology unit Faculty of Medicine, Banha University | ||||
3MBBCH | ||||
Abstract | ||||
Background: Diabetes mellitus (DM) is strongly associated with chronic hepatitis C virus (HCV) infection. This work aimed to estimate the impact of Hepatitis C virus infection on glycaemic state and insulin resistance in type 2 Diabetic patients, and evaluate the effect of direct-acting oral antiviral treatment on the glycaemic state and insulin resistance in type 2 Diabetic patients. Methods: The study was performed on (40 patients) with Type 2 Diabetes who were infected by Hepatitis C Virus and took Direct-acting Oral Antiviral Drugs. The study also included (10 patients) who had Type 2 Diabetes and HCV infection serving as control group. All patients and control were subjected to thorough history taking, clinical examination, and lab. investigations as FBG, PP and HBA1c , Serum fasting Insulin level, And HOMA-IR, HCVab – HBsAg – HIVab, CBC, SGOT, SGPT, Serum Albumin and Bilirubin, PCR for HCV RNA, and Abdominal US. Results: DAAs-based eradication of HCV is associated with improved glycemic control in patients with type 2 diabetes as evidenced by a significant reduction of mean FBG, Fasting insulin, HbA1c, and HOMA IR. There was a positive correlation between the treatment of HCV infection and the reduction of anti-diabetic drugs used in the studied patients. Conclusion: DAAs-based eradication of HCV is associated with improved glycemic control in patients with type 2 diabetes. | ||||
Keywords | ||||
HCV; DAAs; Type 2 DM | ||||
Statistics Article View: 133 PDF Download: 326 |
||||